Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Nov;87(21):8306–8310. doi: 10.1073/pnas.87.21.8306

Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.

L M Forrester 1, G E Neal 1, D J Judah 1, M J Glancey 1, C R Wolf 1
PMCID: PMC54944  PMID: 2122459

Abstract

Liver cancer is a major cause of premature death in many areas of Africa and Asia and its incidence is strongly correlated with exposure to aflatoxin B1 (AFB1). Because AFB1 requires metabolic activation to achieve a biological response, there is a need for detailed knowledge of the mechanism of activation to assess individual risk. We have carried out an extensive study using a total of 19 human liver samples to determine the individual variability in the metabolism of the toxin to mutagenic or detoxification products and to identify the specific cytochrome P-450 forms involved in these processes. Metabolism to the toxic 8,9-epoxide or to products mutagenic in the Ames test was found to exhibit very large individual variation. The rates of metabolic activation were highly correlated with both the level of proteins of the P450IIIA gene family and with the total cytochrome P-450 content of the microsomes. In agreement with this, antibodies reacting with P450IIIA proteins were strong inhibitors of both the metabolism and mutagenicity in the majority of the samples. However, the inhibition varied between 50% and 100%. The expression of a protein in the P450IIC gene family also correlated with AFB1 metabolism and mutagenicity. This result therefore indicated the involvement of cytochromes other than P450IIIA in the activation of AFB1 by human liver microsomes. This hypothesis was strongly supported by the finding that antibodies to P450IA2 and P450IIA1 were also effective inhibitors of metabolism in many of the samples. These data demonstrate that, although P450IIIA probably plays an important role in AFB1 activation, several other cytochrome P-450 forms have the capacity to activate the toxin. Similar considerations apply to detoxifying metabolism to aflatoxin Q1 and aflatoxin M1. The levels of expression of many of the forms of cytochrome P-450 involved in AFB1 metabolism are known to be highly sensitive to environmental factors. This indicates that such factors will be an important determinant in individual susceptibility to the tumorigenic action of AFB1.

Full text

PDF
8306

Images in this article

8307Image
on p.8307
8308Image
on p.8308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Mccann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975 Dec;31(6):347–364. doi: 10.1016/0165-1161(75)90046-1. [DOI] [PubMed] [Google Scholar]
  2. Ball S. E., Forrester L. M., Wolf C. R., Back D. J. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes. Biochem J. 1990 Apr 1;267(1):221–226. doi: 10.1042/bj2670221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elshourbagy N. A., Guzelian P. S. Separation, purification, and characterization of a novel form of hepatic cytochrome P-450 from rats treated with pregnenolone-16 alpha-carbonitrile. J Biol Chem. 1980 Feb 25;255(4):1279–1285. [PubMed] [Google Scholar]
  4. Gonzalez F. J. The molecular biology of cytochrome P450s. Pharmacol Rev. 1988 Dec;40(4):243–288. [PubMed] [Google Scholar]
  5. Hall M., Forrester L. M., Parker D. K., Grover P. L., Wolf C. R. Relative contribution of various forms of cytochrome P450 to the metabolism of benzo[a]pyrene by human liver microsomes. Carcinogenesis. 1989 Oct;10(10):1815–1821. doi: 10.1093/carcin/10.10.1815. [DOI] [PubMed] [Google Scholar]
  6. Harris C. C., Sun T. Multifactoral etiology of human liver cancer. Carcinogenesis. 1984 Jun;5(6):697–701. doi: 10.1093/carcin/5.6.697. [DOI] [PubMed] [Google Scholar]
  7. Ishii K., Maeda K., Kamataki T., Kato R. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450. Mutat Res. 1986 Jun;174(2):85–88. doi: 10.1016/0165-7992(86)90095-3. [DOI] [PubMed] [Google Scholar]
  8. Juvonen R. O., Shkumatov V. M., Lang M. A. Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. Eur J Biochem. 1988 Jan 15;171(1-2):205–211. doi: 10.1111/j.1432-1033.1988.tb13777.x. [DOI] [PubMed] [Google Scholar]
  9. Kawajiri K., Yonekawa H., Harada N., Noshiro M., Omura T., Tagashira Y. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens. Cancer Res. 1980 May;40(5):1652–1657. [PubMed] [Google Scholar]
  10. Kawano S., Kamataki T., Maeda K., Kato R., Nakao T., Mizoguchi I. Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver. Fundam Appl Toxicol. 1985 Jun;5(3):487–498. doi: 10.1016/0272-0590(85)90096-x. [DOI] [PubMed] [Google Scholar]
  11. Koser P. L., Faletto M. B., Maccubbin A. E., Gurtoo H. L. The genetics of aflatoxin B1 metabolism. Association of the induction of aflatoxin B1-4-hydroxylase with the transcriptional activation of cytochrome P3-450 gene. J Biol Chem. 1988 Sep 5;263(25):12584–12595. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lewis A. D., Hickson I. D., Robson C. N., Harris A. L., Hayes J. D., Griffiths S. A., Manson M. M., Hall A. E., Moss J. E., Wolf C. R. Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8511–8515. doi: 10.1073/pnas.85.22.8511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Metcalfe S. A., Colley P. J., Neal G. E. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro. Chem Biol Interact. 1981 May;35(2):145–157. doi: 10.1016/0009-2797(81)90139-3. [DOI] [PubMed] [Google Scholar]
  15. Miles J. S., Bickmore W., Brook J. D., McLaren A. W., Meehan R., Wolf C. R. Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity. Nucleic Acids Res. 1989 Apr 25;17(8):2907–2917. doi: 10.1093/nar/17.8.2907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Neal G. E., Judah D. J., Stirpe F., Patterson D. S. The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B1 by the metabolism of aflatoxin B1 by liver microsomes isolated from certain avian and mammalian species and the possible role of this metabolite in the acute toxicity of aflatoxin B1. Toxicol Appl Pharmacol. 1981 May;58(3):431–437. doi: 10.1016/0041-008x(81)90095-8. [DOI] [PubMed] [Google Scholar]
  17. Neal G. E., Nielsch U., Judah D. J., Hulbert P. B. Conjugation of model substrates or microsomally-activated aflatoxin B1 with reduced glutathione, catalysed by cytosolic glutathione-S-transferases in livers of rats, mice and guinea pigs. Biochem Pharmacol. 1987 Dec 15;36(24):4269–4276. doi: 10.1016/0006-2952(87)90669-1. [DOI] [PubMed] [Google Scholar]
  18. Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B. The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA. 1989 Jan-Feb;8(1):1–13. doi: 10.1089/dna.1.1989.8.1. [DOI] [PubMed] [Google Scholar]
  19. Negishi M., Lindberg R., Burkhart B., Ichikawa T., Honkakoski P., Lang M. Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase. Biochemistry. 1989 May 16;28(10):4169–4172. doi: 10.1021/bi00436a007. [DOI] [PubMed] [Google Scholar]
  20. O'Brien K., Moss E., Judah D., Neal G. Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicity. Biochem Biophys Res Commun. 1983 Jul 29;114(2):813–821. doi: 10.1016/0006-291x(83)90854-9. [DOI] [PubMed] [Google Scholar]
  21. Robertson I. G., Zeiger E., Goldstein J. A. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1. Carcinogenesis. 1983;4(1):93–96. doi: 10.1093/carcin/4.1.93. [DOI] [PubMed] [Google Scholar]
  22. Robertson L. G., Philpot R. M., Zeiger E., Wolf C. R. Specificity of rabbit pulmonary cytochrome P-450 isozymes in the activation of several aromatic amines and aflatoxin B1. Mol Pharmacol. 1981 Nov;20(3):662–668. [PubMed] [Google Scholar]
  23. Ryan D. E., Thomas P. E., Reik L. M., Levin W. Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes. Xenobiotica. 1982 Nov;12(11):727–744. doi: 10.3109/00498258209038947. [DOI] [PubMed] [Google Scholar]
  24. Shimada T., Guengerich F. P. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci U S A. 1989 Jan;86(2):462–465. doi: 10.1073/pnas.86.2.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shimada T., Misono K. S., Guengerich F. P. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909–921. [PubMed] [Google Scholar]
  26. Shimada T., Okuda Y. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver. Biochem Pharmacol. 1988 Feb 1;37(3):459–465. doi: 10.1016/0006-2952(88)90215-8. [DOI] [PubMed] [Google Scholar]
  27. Swenson D. H., Lin J. K., Miller E. C., Miller J. A. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res. 1977 Jan;37(1):172–181. [PubMed] [Google Scholar]
  28. Swenson D. H., Miller J. A., Miller E. C. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. Cancer Res. 1975 Dec;35(12):3811–3823. [PubMed] [Google Scholar]
  29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wolf C. R., Miles J. S., Seilman S., Burke M. D., Rospendowski B. N., Kelly K., Smith W. E. Evidence that the catalytic differences of two structurally homologous forms of cytochrome P-450 relate to their heme environment. Biochemistry. 1988 Mar 8;27(5):1597–1603. doi: 10.1021/bi00405a031. [DOI] [PubMed] [Google Scholar]
  31. Wolf C. R., Oesch F. Isolation of a high spin form of cytochrome P-450 induced in rat liver by 3-methylcholanthrene. Biochem Biophys Res Commun. 1983 Mar 16;111(2):504–511. doi: 10.1016/0006-291x(83)90335-2. [DOI] [PubMed] [Google Scholar]
  32. Wolf C. R., Seilman S., Oesch F., Mayer R. T., Burke M. D. Multiple forms of cytochrome P-450 related to forms induced marginally by phenobarbital. Differences in structure and in the metabolism of alkoxyresorufins. Biochem J. 1986 Nov 15;240(1):27–33. doi: 10.1042/bj2400027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wolff T., Distlerath L. M., Worthington M. T., Groopman J. D., Hammons G. J., Kadlubar F. F., Prough R. A., Martin M. V., Guengerich F. P. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res. 1985 May;45(5):2116–2122. [PubMed] [Google Scholar]
  34. Zeiger E., Pagano D. A., Robertson I. G. A rapid and simple scheme for confirmation of Salmonella tester strain phenotype. Environ Mutagen. 1981;3(3):205–209. doi: 10.1002/em.2860030303. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES